These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 29367258)
1. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors. Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258 [TBL] [Abstract][Full Text] [Related]
2. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics. Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of pepducins as Gs-biased allosteric agonists. Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624 [TBL] [Abstract][Full Text] [Related]
4. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899 [TBL] [Abstract][Full Text] [Related]
5. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor. Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238 [TBL] [Abstract][Full Text] [Related]
8. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ; Leurs R; de Esch IJ; de Graaf C J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966 [TBL] [Abstract][Full Text] [Related]
9. Biased Signaling of the G-Protein-Coupled Receptor β Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323 [TBL] [Abstract][Full Text] [Related]
10. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? Tang H; Wang XS; Hsieh JH; Tropsha A Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072 [TBL] [Abstract][Full Text] [Related]
11. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor. Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065 [TBL] [Abstract][Full Text] [Related]
12. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812 [TBL] [Abstract][Full Text] [Related]
13. Unique Positive Cooperativity Between the Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163 [TBL] [Abstract][Full Text] [Related]
14. G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation. Ichikawa O; Fujimoto K; Yamada A; Okazaki S; Yamazaki K PLoS One; 2016; 11(5):e0155816. PubMed ID: 27187591 [TBL] [Abstract][Full Text] [Related]
15. Does Divergent Binding Pocket Closure Drive Ligand Bias for Class A GPCRs? Bermudez M; Bock A Trends Pharmacol Sci; 2019 Apr; 40(4):236-239. PubMed ID: 30852058 [TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Positive Allosteric Modulators of the Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246 [TBL] [Abstract][Full Text] [Related]
17. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. Vaidehi N; Kenakin T Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468 [TBL] [Abstract][Full Text] [Related]
18. Modeling G protein-coupled receptors in complex with biased agonists. Costanzi S Trends Pharmacol Sci; 2014 Jun; 35(6):277-83. PubMed ID: 24793542 [TBL] [Abstract][Full Text] [Related]